Mail

UK markets close in 4 minutes

FTSE 100
8,142.40
+63.54(+0.79%)
FTSE 250
19,826.77
+224.79(+1.15%)
AIM
755.43
+2.31(+0.31%)
GBP/EUR
1.1664
+0.0007(+0.06%)
GBP/USD
1.2453
-0.0058(-0.46%)
Bitcoin GBP
51,096.77
+60.30(+0.12%)

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

Premier Biomedical, Inc. (BIEI)

Other OTC - Other OTC Delayed price. Currency in USD

Add to watchlist

0.0013

0.0000

(0.00%)

As of 03:34PM EDT. Market open.

Currency in USD

Valuation measures⁴

Market cap (intra-day)	1.60M
Enterprise value	1.60M
Trailing P/E	N/A
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	5.87
Price/book (mrq)	N/A
Enterprise value/revenue	112.03
Enterprise value/EBITDA	76.52

Trading information

Stock price history

Beta (5Y monthly)	-4.16
52-week change ³	8.33%
S&P500 52-week change ³	21.08%
52-week high ³	0.0017
52-week low ³	0.0005
50-day moving average ³	0.0011
200-day moving average ³	0.0009

Share statistics

Avg vol (3-month) ³	1.72M
Avg vol (10-day) ³	1.24M
Shares outstanding ⁵	999.98M
Implied shares outstanding ⁶	1.23B
Float ⁸	976.3M
% held by insiders ¹	2.37%
% held by institutions ¹	0.00%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	27 Jun 2018
Ex-dividend date ⁴	N/A
Last split factor ²	1:250
Last split date ³	27 Jun 2018

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2019
Most-recent quarter (mrq)	31 Dec 2019

Profitability

Profit margin	0.00%
Operating margin (ttm)	-8,196.55%

Management effectiveness

Return on assets (ttm)	-153.58%
Return on equity (ttm)	N/A

Income statement

Revenue (ttm)	14.28k
Revenue per share (ttm)	0.00
Quarterly revenue growth (yoy)	-85.60%
Gross profit (ttm)	N/A
EBITDA	-323.9k
Net income avi to common (ttm)	-374.47k
Diluted EPS (ttm)	-0.0100
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	71.2k
Total cash per share (mrq)	0
Total debt (mrq)	160.75k
Total debt/equity (mrq)	N/A
Current ratio (mrq)	0.05
Book value per share (mrq)	-0.01

Cash flow statement

Operating cash flow (ttm)	-344.18k
Levered free cash flow (ttm)	-310.46k